Patel Sanj K bought KNSA
April 1, 2026 · Form 4 insider transaction
Patel Sanj K bought 21,327 shares of Kiniksa Pharmaceuticals International, plc, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
21,327
Price
N/A
Total value
N/A
InsiderPatel Sanj K
RoleOfficer, Director
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateApril 1, 2026
Filing dateApril 3, 2026
Shares owned after81,327
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.